Protein C activated - BioatrixAlternative Names: aPC - Bioatrix
Latest Information Update: 18 Mar 2016
At a glance
- Originator University of Sydney
- Developer Bioatrix
- Class Anticoagulants; Antithrombotics; Biological factors; Blood proteins; Enzyme precursors; Glycoproteins
- Mechanism of Action Protein C stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Wounds